- Home
- BME vs CYRX Comparison
BME vs CYRX Comparison
Compare BME & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- CYRX
- Stock Information
- Founded
- BME 2005
- CYRX 1999
- Country
- BME United States
- CYRX United States
- Employees
- BME N/A
- CYRX N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- BME Finance
- CYRX Health Care
- Exchange
- BME Nasdaq
- CYRX Nasdaq
- Market Cap
- BME 474.7M
- CYRX 438.7M
- IPO Year
- BME N/A
- CYRX N/A
- Fundamental
- Price
- BME $36.41
- CYRX $8.87
- Analyst Decision
- BME
- CYRX Strong Buy
- Analyst Count
- BME 0
- CYRX 10
- Target Price
- BME N/A
- CYRX $11.70
- AVG Volume (30 Days)
- BME 34.0K
- CYRX 578.2K
- Earning Date
- BME 01-01-0001
- CYRX 11-06-2025
- Dividend Yield
- BME 6.26%
- CYRX N/A
- EPS Growth
- BME N/A
- CYRX N/A
- EPS
- BME 1.44
- CYRX 1.35
- Revenue
- BME N/A
- CYRX $237,879,000.00
- Revenue This Year
- BME N/A
- CYRX N/A
- Revenue Next Year
- BME N/A
- CYRX $9.08
- P/E Ratio
- BME $28.37
- CYRX $6.57
- Revenue Growth
- BME N/A
- CYRX 24.93
- 52 Week Low
- BME $35.53
- CYRX $4.58
- 52 Week High
- BME $43.20
- CYRX $10.46
- Technical
- Relative Strength Index (RSI)
- BME 44.93
- CYRX 50.42
- Support Level
- BME $37.03
- CYRX $8.53
- Resistance Level
- BME $37.58
- CYRX $10.46
- Average True Range (ATR)
- BME 0.32
- CYRX 0.58
- MACD
- BME -0.09
- CYRX -0.10
- Stochastic Oscillator
- BME 12.31
- CYRX 31.76
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.